Atlas Trials

A Real-World Study of Toripalimab in Chinese Patients With Lung Cancer(THUNDER Study)

Clinical trial NCT05652712 · UNKNOWN

Trial details

NCT number
NCT05652712
Sponsor
Qianfoshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2019-01-01
Primary completion
2022-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.